Kwang Dong Pharmaceutical Co., Ltd. (009290.KS)
KRW 5670.0
(0.0%)
KRW 5670.0
(0.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 1514.45 Billion | 1431.54 Billion | 1338.18 Billion | 1243.76 Billion | 1238.25 Billion | 1180.21 Billion |
| Cost of Revenue | 1219.33 Billion | 1149.49 Billion | 1063.92 Billion | 986.06 Billion | 979.58 Billion | 938.62 Billion |
| Gross Profit | 295.11 Billion | 282.04 Billion | 274.25 Billion | 257.7 Billion | 258.66 Billion | 241.59 Billion |
| Operating Expenses | 249.12 Billion | 243.8 Billion | 229.31 Billion | 211.11 Billion | 216.86 Billion | 207.64 Billion |
| Selling, General and Administrative Expenses | 233.84 Billion | 140.91 Billion | 137.23 Billion | 124.25 Billion | 128.83 Billion | 121.37 Billion |
| Research and Development Expenses | 15.27 Billion | 9.67 Billion | 8.32 Billion | 5.95 Billion | 5.33 Billion | 4.17 Billion |
| Other Expenses | - | 93.21 Billion | 83.75 Billion | 80.91 Billion | 82.68 Billion | 748.76 Million |
| Cost and Expenses | 1465.68 Billion | 1393.3 Billion | 1293.24 Billion | 1197.17 Billion | 1196.45 Billion | 1146.27 Billion |
| Operating Income | 48.76 Billion | 38.24 Billion | 44.93 Billion | 46.59 Billion | 41.8 Billion | 33.94 Billion |
| Interest Expense | 6.9 Billion | 3.73 Billion | 2.54 Billion | 2.53 Billion | 3.17 Billion | 2.78 Billion |
| Income Tax Expense | 9.64 Billion | 9.59 Billion | 8.78 Billion | 17.34 Billion | 14.11 Billion | 9.42 Billion |
| Earnings before Tax | 49.01 Billion | 36.29 Billion | 34.32 Billion | 62.95 Billion | 36.76 Billion | 31.39 Billion |
| Net Income | 36.96 Billion | 24.17 Billion | 24.01 Billion | 45.36 Billion | 23.05 Billion | 22.34 Billion |
| Earnings Per Share Basic | 913.39 | 588.45 | 584.68 | 1119.49 | 581.72 | 551.00 |
| Earnings Per Share Diluted | 913.39 | 588.45 | 584.33 | 1119.49 | 581.72 | 551.00 |
| Weighted Average Shares Outstanding | 40.47 Million | 41.08 Million | 41.08 Million | 40.52 Million | 39.63 Million | 40.55 Million |
| Weighted Average Shares Outstanding (Diluted) | 40.47 Million | 41.08 Million | 41.12 Million | 40.52 Million | 39.63 Million | 40.55 Million |
| Gross Margin | 0.19 | 0.20 | 0.20 | 0.21 | 0.21 | 0.20 |
| EBIT Margin | 0.04 | 0.04 | 0.05 | 0.06 | 0.05 | 0.05 |
| Profit Margin | 0.02 | 0.02 | 0.02 | 0.04 | 0.02 | 0.02 |
| EBITDA | 54.97 Billion | 54.51 Billion | 51.02 Billion | 85.19 Billion | 58.72 Billion | 51.59 Billion |
| Earnings Before Tax Margin | 0.03 | 0.03 | 0.03 | 0.04 | 0.03 | 0.03 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 412.81 Billion | 412.48 Billion | 1514.45 Billion | 384.3 Billion | 397.83 Billion | 375.35 Billion |
| Cost of Revenue | 339.07 Billion | 334.03 Billion | 1219.33 Billion | 313.56 Billion | 320.14 Billion | 298.28 Billion |
| Gross Profit | 73.74 Billion | 78.45 Billion | 295.11 Billion | 70.74 Billion | 77.69 Billion | 77.07 Billion |
| Operating Expenses | 407.77 Billion | 61.42 Billion | 253.84 Billion | 67.48 Billion | -66.61 Billion | -65.14 Billion |
| Selling, General and Administrative Expenses | 66.14 Billion | 57.92 Billion | - | 63.75 Billion | 66.61 Billion | 65.14 Billion |
| Research and Development Expenses | 2.56 Billion | 2.52 Billion | - | 2.93 Billion | 2.15 Billion | 2.43 Billion |
| Other Expenses | -407.77 Billion | -974.02 Million | -2.78 Billion | -797.27 Million | -133.23 Billion | -130.28 Billion |
| Cost and Expenses | 407.77 Billion | 395.45 Billion | 1473.17 Billion | 381.04 Billion | 320.14 Billion | 298.28 Billion |
| Operating Income | 5.04 Billion | 17.02 Billion | 41.27 Billion | 3.26 Billion | 11.07 Billion | 11.92 Billion |
| Interest Expense | - | 2.5 Billion | 6.9 Billion | 1.91 Billion | 1.93 Billion | 1.79 Billion |
| Income Tax Expense | 876 Million | 7.26 Billion | 9.64 Billion | 5.36 Billion | 1.82 Billion | 3.83 Billion |
| Earnings before Tax | 2.57 Billion | 25.72 Billion | 47.7 Billion | 10.27 Billion | 11.14 Billion | 12.83 Billion |
| Net Income | 1.32 Billion | 18.2 Billion | 36.96 Billion | 5.53 Billion | 8.83 Billion | 8.55 Billion |
| Earnings Per Share Basic | 42.36 | 454.09 | - | 138.05 | 220.32 | 210.48 |
| Earnings Per Share Diluted | 42.36 | 454.09 | - | 138.05 | 220.32 | 210.48 |
| Weighted Average Shares Outstanding | 40.08 Million | 40.08 Million | 40.47 Million | 40.08 Million | 40.08 Million | 40.65 Million |
| Weighted Average Shares Outstanding (Diluted) | 40.08 Million | 40.08 Million | 40.47 Million | 40.08 Million | 40.08 Million | 40.65 Million |
| Gross Margin | 0.18 | 0.19 | 0.19 | 0.18 | 0.20 | 0.21 |
| EBIT Margin | 0.01 | 0.05 | - | 0.02 | 0.20 | 0.21 |
| Profit Margin | 0.00 | 0.04 | 0.02 | 0.01 | 0.02 | 0.02 |
| EBITDA | 5.04 Billion | 20.84 Billion | - | 6.16 Billion | 77.69 Billion | 77.07 Billion |
| Earnings Before Tax Margin | 0.01 | 0.04 | 0.03 | 0.01 | 0.03 | 0.03 |
4167
PKCOF
216050
008730
PXMFF
000050